Mangiameli Giuseppe, Cioffi Ugo, Alloisio Marco, Testori Alberto
Division of Thoracic Surgery, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano – Milan, Italy
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele – Milan, Italy
Lung cancer is the second most diagnosed cancer and was the primary cause of cancer death worldwide in 2020. Lung cancer treatment is associated with huge costs for patients and society. Consequently, there is an increasing interest on prevention, early detection with screening, and development of new treatments. Surgical management accounts for at least 90% of the activity of thoracic surgery departments. Surgery is the treatment of choice for stages I and II non-small cell lung cancer. In this chapter, we discuss the state of art of thoracic surgery for surgical management of lung cancer. We start describing the milestones of lung cancer treatment, lobectomy, and lymphadenectomy, followed by a description of the traditional and innovative approaches that are currently available. Open lobectomy, and mini-invasive approaches including video-assisted thoracoscopic surgery and robotic assisted thoracoscopic surgery are covered. A brief overview of the innovation and future perspective in thoracic surgery are presented.
肺癌是第二大最常被诊断出的癌症，并且在2020年是全球癌症死亡的主要原因。肺癌治疗给患者和社会带来了巨大的成本。因此，人们对预防、通过筛查进行早期检测以及新治疗方法的开发越来越感兴趣。手术管理至少占胸外科科室活动的90%。手术是I期和II期非小细胞肺癌的首选治疗方法。在本章中，我们讨论肺癌手术管理的胸外科技术现状。我们首先描述肺癌治疗、肺叶切除术和淋巴结清扫术的里程碑，然后描述目前可用的传统和创新方法。涵盖了开放肺叶切除术以及包括电视辅助胸腔镜手术和机器人辅助胸腔镜手术在内的微创方法。还简要概述了胸外科的创新和未来前景。
